Turku, Finland

John E Eriksson

USPTO Granted Patents = 5 


 

Average Co-Inventor Count = 4.6

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Abo, FI (2015)
  • Turku, FI (2006 - 2017)

Company Filing History:


Years Active: 2006-2017

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: John E Eriksson: Innovator in Pharmaceutical Compositions

Introduction

John E Eriksson is a notable inventor based in Turku, Finland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions for cancer treatment. With a total of five patents to his name, Eriksson's work is paving the way for new therapeutic approaches.

Latest Patents

Eriksson's latest patents include groundbreaking work on pharmaceutical compositions of Anisomelic acid. This composition is designed for anti-viral cancer treatment in mammals and comprises a therapeutically effective amount of Anisomelic acid or its salts. The formulation may be presented in an oil-in-water emulsion or in a hydrophilic solvent combined with co-solvents or surfactants. Additionally, he has developed a method for treating or preventing cancer in mammals where the p53 pathway is deregulated by viral oncoproteins. Another significant invention focuses on combination therapy, which is based on the discovery that silencing the PME-1 gene can sensitize cancer cells to the apoptosis-inducing effects of certain small molecule chemotherapeutic agents.

Career Highlights

Throughout his career, Eriksson has worked with various companies, including Hormos Nutraceutical Oy Ltd. His innovative research and development efforts have positioned him as a key figure in the pharmaceutical industry.

Collaborations

Eriksson has collaborated with talented individuals such as Emilia Peuhu and Preethy Paul, contributing to the advancement of his research and inventions.

Conclusion

John E Eriksson's contributions to pharmaceutical innovations demonstrate his commitment to improving cancer treatment options. His work continues to inspire advancements in the field, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…